ÂÜÀòÂÒÂ×

Scott Huennekens is a highly accomplished executive with extensive experience in leadership roles across several companies. Currently serving as the Executive Chairperson of the Board at Elucid and On Target Laboratories, Huennekens also holds prominent positions as a Board Member at Veranex, Proximie, Q'Apel Medical, Inc., and Foldax Inc., as well as Chairperson of the Board at Envista Holdings Corporation, Hyperfine, and KARDION GmbH. Since 2019, Huennekens has been the Principal at Front Foot Ventures. Huennekens earned an MBA with a focus on Entrepreneurship from Harvard Business School and holds a Bachelor's degree in Business with an emphasis in Accounting from the University of Southern California.